Page last updated: 2024-10-18

glycine and Sarcoma, Synovial

glycine has been researched along with Sarcoma, Synovial in 1 studies

Sarcoma, Synovial: A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Perani, M1
Antonson, P1
Hamoudi, R1
Ingram, CJ1
Cooper, CS1
Garrett, MD1
Goodwin, GH1

Other Studies

1 other study available for glycine and Sarcoma, Synovial

ArticleYear
The proto-oncoprotein SYT interacts with SYT-interacting protein/co-activator activator (SIP/CoAA), a human nuclear receptor co-activator with similarity to EWS and TLS/FUS family of proteins.
    The Journal of biological chemistry, 2005, Dec-30, Volume: 280, Issue:52

    Topics: Amino Acid Motifs; Amino Acid Sequence; Animals; Cell Cycle Proteins; Cell Line; Cell Line, Tumor; C

2005